New Treatments & Clinical Trials for Traumatic Brain Injury

Traumatic brain injury affects roughly 2.8 million Americans each year, ranging from concussions to severe injuries that cause lasting disability. Treatment focuses on preventing further damage, managing swelling and pressure in the brain, and supporting recovery through rehabilitation. Many people recover fully from mild TBI, but moderate and severe injuries often leave cognitive, emotional, or physical effects.

What's actually going on in research

Trials are testing drugs to protect brain cells after injury, treatments to reduce inflammation and swelling, stem cell approaches to repair damaged tissue, and devices that monitor brain pressure or stimulate recovery. Researchers are also studying chronic effects of repeated mild TBI, developing better ways to predict who will recover, and testing rehabilitation techniques that use brain imaging to guide therapy.

What to know before you search

Eligibility typically depends on injury severity, time since injury, age, specific symptoms or complications, and whether other medical conditions are present.

What types of trials are currently open

• Acute treatment trials — Testing drugs or procedures given in the emergency room or ICU to limit brain damage in the first hours or days after injury.
• Rehabilitation trials — Testing physical therapy, cognitive training, speech therapy, or other approaches to improve recovery weeks to years after injury.
• Device trials — Studies of brain stimulation devices, pressure monitors, or other technologies used during recovery.
• Biomarker studies — Testing blood tests or imaging methods that might predict recovery, guide treatment decisions, or detect ongoing brain damage.
• Long-term outcome studies — Following people for months or years after TBI to understand lasting effects and what factors predict better or worse outcomes.